| Autor: |
Kara, F, Kiran, G, Metindir, J, Ozan, H, Ozalp, S, Vardar, MA, Zeren, H, Dilek, S, Bozkaya, H, Guven, S, Ersoz, S, Acikalm, A, Meydanli, M, Cetinarslan, I, Gokaslan, H, Eren, F, Celik, C, Yilmaz, O, Celik, H, Aksaz, Z, Kocak, C, Bagci, H, Davutoglu, BS, Hakverdi, AU, Soysal, Mehmet Emin, Kaya, G, Yanik, A, Arici, S, Cetin, H, Mutlu, AE, Kolusari, A, Kosem, M, Sahin, G, Demirturk, F, Gultekin, M, Karaca, M, Harma, M, Batur, S, Demirbag, N, Baykal, C, Dogan, I, Sam, AD |
| Jazyk: |
angličtina |
| Rok vydání: |
2009 |
| Předmět: |
|
| Popis: |
Objective: To evaluate retrospectively the prevalence of cervical cytological abnormalities in patient records obtained from healthcare centers in Turkey. Method: Demographic characteristics and data on cervical cytological abnormalities were evaluated from patients who underwent flap tests in healthcare centers in 2007. Results: Data were collected from 33 healthcare centers totaling 140 334 patients. Overall, the prevalence of cervical cytological abnormalities was 1.8%; the prevalence of ASCUS, ASC-H, LSIL, HSIL, and AGC was 1.07%, 0.07%, 0.3%, 0.17%, and 0.08%, respectively. The prevalence of preinvasive cervical neoplasia was 1.7% and the prevalence of cytologically diagnosed invasive neoplasia was 0.06%. Conclusion: The abnormal cervical cytological prevalence rate in Turkey is lower than in Europe and North America. This might be due to sociocultural differences, lack of population-based screening programs, or a lower HPV prevalence rate in Turkey. (C) 2009 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
